| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2011 | US7919521 Five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics |
| 04/05/2011 | US7919520 Inhibitors of tace |
| 04/05/2011 | US7919519 1-(4-(5-Phenylbenzofuran-2-yl)benzyl)azetidine-3-carboxylic acids; anticarcinogenic, antiinflammatory, antiarthritic, antidiabetic agents; transplant rejection, autoimmune diseases, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, Chron's disease |
| 04/05/2011 | US7919518 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| 04/05/2011 | US7919517 Indazole derivatives |
| 04/05/2011 | US7919516 Deuterium-enriched ondansetron |
| 04/05/2011 | US7919515 3-phenylpropionic acid derivatives |
| 04/05/2011 | US7919514 Protein kinase B inhibitors; anticarcinogenic, antiinflammatory and antiproliferative agents; metabolic disorders; 3-(3-fluoro-phenyl)-N-[5-(3-methyl-1H-indazol-5-yl)-[1,3,4]thiadiazol-2-yl]-propane-1,2-diamine and derivatives |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919512 Compounds having CRTH2 antagonist activity |
| 04/05/2011 | US7919511 Aminopyridines, e.g., 6-(2-cyanophenyl)-4-{[2-(3-fluorophenyl)ethyl]amino}(3-pyridyl))-N-(3-pyridylmethyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 04/05/2011 | US7919509 2-oxochromene derivatives |
| 04/05/2011 | US7919508 3-piperidinylisochroman-5-ols as dopamine agonists |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919506 Dibenzyl amine compounds and derivatives |
| 04/05/2011 | US7919505 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 04/05/2011 | US7919504 Thiadiazole modulators of PKB |
| 04/05/2011 | US7919503 P2X7R antagonists and their use |
| 04/05/2011 | US7919502 Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors |
| 04/05/2011 | US7919500 Bis-carbazole DNA intercalating agents for antitumor therapy |
| 04/05/2011 | US7919499 Naltrexone long acting formulations and methods of use |
| 04/05/2011 | US7919498 Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors |
| 04/05/2011 | US7919497 Analogs of dehydrophenylahistins and their therapeutic use |
| 04/05/2011 | US7919496 5-[4-(2-Trifluoromethylbenzoyl)piperazin-1-yl]-[1,3,4]thiadiazole-2-carboxylic acid ethyl ester; metabolic disorders type II diabetes, impaired glucose tolerance, insulin resistance, obesity, fatty liver, non-alcoholic steatohepatitis, dyslipidemia and metabolic syndrome; cardiovascular disorders |
| 04/05/2011 | US7919495 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound |
| 04/05/2011 | US7919494 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound |
| 04/05/2011 | US7919493 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 04/05/2011 | US7919492 Compounds |
| 04/05/2011 | US7919491 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | US7919489 e.g. 4-({[(4-Chloro-2-methylphenyl)amino]carbonyl}amino)-1-(cyclopropylmethyl)-1H-imidazole-2-carboxylic acid; antiviral agents, especially against cytomegaloviruses and other Herpes viridae; side effect reduction; antibiotic resistance |
| 04/05/2011 | US7919488 Therapeutic compounds |
| 04/05/2011 | US7919487 Heteroaryl compounds |
| 04/05/2011 | US7919486 Use of gallium(III) complexes for the treatment of melanomas |
| 04/05/2011 | US7919485 Protein kinase targeted therapeutics |
| 04/05/2011 | US7919484 Combination therapy |
| 04/05/2011 | US7919483 Method for the treatment of acne |
| 04/05/2011 | US7919481 Inositol pyrophosphates, and methods of use thereof |
| 04/05/2011 | US7919480 Polymers having covalently bound antibiotic agents |
| 04/05/2011 | US7919479 Antiadhesive carbohydrates |
| 04/05/2011 | US7919477 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 04/05/2011 | US7919473 IRNA agents targeting VEGF |
| 04/05/2011 | US7919470 Glycopeptide composition with improved antibiotic activity |
| 04/05/2011 | US7919458 Method of inhibiting prostate cancer cell proliferation |
| 04/05/2011 | US7919454 Methods of treating using conjugates transported by a PEPT2 transporter |
| 04/05/2011 | US7919311 Compositions and methods for activating genes of interest |
| 04/05/2011 | US7919309 Method for expression of small antiviral RNA molecules within a cell |
| 04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/05/2011 | US7919130 Method for crosslinking β-cyclodextrin for cholesterol trapping and regeneration thereof |
| 04/05/2011 | US7919129 System and method for spraying meat products with an anti-microbial agent |
| 04/05/2011 | US7919125 Modulation of inflammation by hops fractions and derivatives |
| 04/05/2011 | US7919123 Composition and method for treating or preventing gastrointestinal cancer |
| 04/05/2011 | US7919117 Drug delivery of fesoterodine (fumarate) through the skin in a dosage ofo.r-20 mg per day and is provided in a polymer matrix for uniform release;contact adhesives; sel-adhesives; impermeable backing; flatness; geratrics;drug delivery; side effect reduction |
| 04/05/2011 | US7919116 Controlled release metformin formulations |
| 04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | US7919075 Coatings for implantable medical devices |
| 04/05/2011 | US7918877 Lateral insertion method for spinous process spacer with deployable member |
| 04/05/2011 | CA2739682A1 Topical nsaid compositions having sensate component |
| 04/05/2011 | CA2598536C Oxyindole derivatives as 5ht4 receptor agonists |
| 04/05/2011 | CA2574822C Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/05/2011 | CA2572577C Synthesis of acyclic nucleoside derivatives |
| 04/05/2011 | CA2537127C Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| 04/05/2011 | CA2526538C Aqueous compositions for disinfection and/or sterilization |
| 04/05/2011 | CA2516600C Process for production of sulfoxide proton pump inhibitors in the amorphous state |
| 04/05/2011 | CA2514878C Drug formulation and delivery using crystalline methylated cyclodextrins |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2483028C Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/05/2011 | CA2476825C Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases |
| 04/05/2011 | CA2476350C Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2474479C Composition for inhalation |
| 04/05/2011 | CA2470168C Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 04/05/2011 | CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 04/05/2011 | CA2463348C Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 04/05/2011 | CA2461703C Modulation of physiological processes and agents useful for same |
| 04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
| 04/05/2011 | CA2439274C Carbamate compounds for use in the treatment of pain |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2379776C A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 04/05/2011 | CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 04/05/2011 | CA2344168C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 04/02/2011 | CA2716231A1 Benzoyl peroxide composition for treating skin |
| 04/02/2011 | CA2715959A1 Surgical compositions |
| 04/02/2011 | CA2713610A1 Ectopic pregnancy treatment |
| 04/02/2011 | CA2680502A1 Benzoyl free formula (bff) acne treatment solution |
| 04/01/2011 | CA2697568A1 Cancer therapy |
| 03/31/2011 | WO2011038385A2 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | WO2011038380A2 Combination |
| 03/31/2011 | WO2011038298A1 Use of dipyridamole in chronic ischemia |
| 03/31/2011 | WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication |